Share This Page
Drug Price Trends for ALAHIST DM
✉ Email this page to a colleague
Average Pharmacy Cost for ALAHIST DM
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ALAHIST DM 2-15-7.5 MG/5 ML LQ | 50991-0826-16 | 0.04837 | ML | 2024-09-18 |
| ALAHIST DM 10-12.5-5 MG/5 ML LQ | 50991-0444-16 | 0.06140 | ML | 2024-06-19 |
| ALAHIST DM 2-15-7.5 MG/5 ML LQ | 50991-0826-16 | 0.04708 | ML | 2024-06-19 |
| ALAHIST DM 2-15-7.5 MG/5 ML LQ | 50991-0826-16 | 0.05310 | ML | 2024-05-22 |
| ALAHIST DM 2-15-7.5 MG/5 ML LQ | 50991-0826-16 | 0.04468 | ML | 2024-04-17 |
| ALAHIST DM 2-15-7.5 MG/5 ML LQ | 50991-0826-16 | 0.04468 | ML | 2024-01-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
ALAHIST DM Market Analysis and Financial Projection
Market Analysis and Price Projections for ALAHIST DM
Overview of ALAHIST DM
ALAHIST DM is a multi-symptom relief medication that combines dextromethorphan HBr, pheniramine maleate, and phenylephrine HCl. It is designed to temporarily relieve symptoms associated with the common cold, hay fever (allergic rhinitis), and other upper respiratory allergies, including cough, nasal congestion, rhinorrhea, and sneezing[1][4].
Market Context: Human Antihistamine Drugs
The human antihistamine drug market, within which ALAHIST DM operates, is experiencing significant growth. Here are some key market trends and projections:
- Market Size and Growth: The human antihistamine drug market is projected to grow from USD 274.8 million in 2023 to USD 706.2 million by 2033, at a Compound Annual Growth Rate (CAGR) of 9.9% between 2024 and 2033[3].
- Dominant Drug Types: Second-generation antihistamines, known for their improved safety profiles and reduced sedative effects, hold over 62.7% of the market share in 2023[3].
- Preferred Medication Type: Over-the-counter (OTC) drugs lead the market with a 60.7% share in 2023, reflecting consumer preference for accessible, non-prescription solutions[3].
Regional Analysis
- North America: This region is a key player in the human antihistamine drug market, securing a substantial 37.2% market share in 2023. The strong market presence in North America is attributed to increased awareness about allergy management, a high incidence of allergic conditions, and a proactive approach to healthcare[3].
Pricing and Cost Considerations for ALAHIST DM
- Current Pricing: The cost of ALAHIST DM without insurance can vary, but a typical price for a 473 mL bottle is around $40.65, with a per-unit cost of $0.09[2].
- Generic Availability: ALAHIST DM does not have a generic version available, which can impact pricing and accessibility[2].
Factors Influencing Price Projections
- Demand and Prevalence of Allergies: The growing global prevalence of allergic conditions drives the demand for antihistamine medications, including ALAHIST DM. This increased demand can lead to stable or rising prices[3].
- Healthcare Infrastructure and Awareness: Expansions in healthcare infrastructure and increasing awareness about allergic disorders contribute to the market expansion and may influence pricing strategies[3].
- Innovations in Drug Research and Development: Advances in drug research and development, particularly in the antihistamine sector, can lead to new products and potentially affect the pricing of existing medications like ALAHIST DM[3].
Big Data and Cloud Utilization
The integration of big data and cloud computing in healthcare can streamline research, development, and delivery of antihistamine medicines. This trend could lead to more efficient production and distribution, potentially stabilizing or reducing costs over time[3].
Healthcare IT Investments
Substantial investments in healthcare IT are expected to foster breakthroughs in antihistamine drug research, development, and distribution. This could lead to more competitive pricing as companies leverage technology to reduce costs and improve efficiency[3].
Price Projections
Given the market trends and growth projections:
- Short-Term (2024-2026): Prices for ALAHIST DM are likely to remain stable or see a slight increase due to the growing demand for antihistamine medications and the lack of generic alternatives.
- Medium-Term (2027-2030): As healthcare IT and big data applications become more prevalent, there could be a slight reduction in prices due to increased efficiency in production and distribution.
- Long-Term (2031-2033): With the market expected to reach USD 706.2 million by 2033, prices may stabilize as the market becomes more competitive, driven by innovations and expanded healthcare infrastructure[3].
Key Takeaways
- The human antihistamine drug market, including ALAHIST DM, is experiencing significant growth driven by increasing allergy prevalence and advancements in healthcare.
- North America is a key region for this market, with a strong preference for OTC antihistamine medications.
- Pricing for ALAHIST DM is expected to remain stable or see slight increases in the short term, with potential reductions in the medium to long term due to technological advancements.
FAQs
Q: What is the current market size of the human antihistamine drug market? A: The human antihistamine drug market size is USD 274.8 million in 2023[3].
Q: What is the projected CAGR for the human antihistamine drug market? A: The market is expected to grow at a CAGR of 9.9% between 2024 and 2033[3].
Q: What are the primary indications for ALAHIST DM? A: ALAHIST DM is used to relieve symptoms of the common cold, hay fever (allergic rhinitis), and other upper respiratory allergies, including cough, nasal congestion, rhinorrhea, and sneezing[1][4].
Q: Is ALAHIST DM available as a generic? A: No, ALAHIST DM does not have a generic version available[2].
Q: How does the integration of big data and cloud computing impact the pricing of antihistamine medications? A: The integration of big data and cloud computing can lead to more efficient production and distribution, potentially stabilizing or reducing costs over time[3].
Sources
- ConnectRx - ALAHIST DM (dextromethorphan hbr/phenylephrine hcl/dexbrompheniramine)[1].
- Drugs.com - Alahist DM vs SudoGest Comparison[2].
- Market.us - Human Antihistamine Drug Market Size | CAGR OF 9.9%[3].
- DailyMed - ALAHIST DM - dextromethorphan hbr, pheniramine maleate, phenylephrine hcl liquid[4].
More… ↓
